Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 1;222(7):1086-1089.
doi: 10.1093/infdis/jiaa429.

Estimation Without Representation: Early Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Studies and the Path Forward

Bonnie E Shook-Sa  1 , Ross M Boyce  2 , Allison E Aiello  3   4
Affiliations

Estimation Without Representation: Early Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Studies and the Path Forward

Bonnie E Shook-Sa et al. J Infect Dis. .

Abstract

The recent development and regulatory approval of a variety of serological assays indicating the presence of antibodies against severe acute respiratory syndrome coronavirus 2 has led to rapid and widespread implementation of seroprevalence studies. Accurate estimates of seroprevalence are needed to model transmission dynamics and estimate mortality rates. Furthermore, seroprevalence levels in a population help guide policy surrounding reopening efforts. The literature to date has focused heavily on issues surrounding the quality of seroprevalence tests and less on the sampling methods that ultimately drive the representativeness of resulting estimates. Seroprevalence studies based on convenience samples are being reported widely and extrapolated to larger populations for the estimation of total coronavirus disease 2019 (COVID-19) infections, comparisons of prevalence across geographic regions, and estimation of mortality rates. In this viewpoint, we discuss the pitfalls that can arise with the use of convenience samples and offer guidance for moving towards more representative and timely population estimates of COVID-19 seroprevalence.

Keywords: COVID-19; address-based sampling; convenience sampling; seroprevalence; transmission.

PubMed Disclaimer

References

    1. Whitehouse.gov and the Centers for Disease Control and Prevention. Guidelines: opening up America again. Available at: https://www.whitehouse.gov/openingamerica. Accessed 9 June 2020.
    1. Akpan N. Here’s how to stop the virus from winning. National Geographic. Available at: https://www.nationalgeographic.com/science/2020/06/how-to-stop-coronavir.... Accessed 1 July 2020.
    1. Winter AK, Hegde ST. The important role of serology for COVID-19 control. Lancet Infect Dis 2020; 20:758–9. - PMC - PubMed
    1. Song J-Y, Yun J-G, Noh J-Y, Cheong H-J, Kim W-J. Covid-19 in South Korea—challenges of subclinical manifestations. N Engl J Med 2020; 382:1858–9. - PMC - PubMed
    1. Mallapaty S. Antibody tests suggest that coronavirus infections vastly exceed official counts. Available at: https://www.nature.com/articles/d41586-020-01095-0. Accessed 9 June 2020. - PubMed

Publication types

MeSH terms

Substances